GnRH analogues in the treatment of endometriosis — rationale and efficacy

This publication has 15 references indexed in Scilit:

• Isolation and properties of the FSH and LH-releasing hormone
  Published by Elsevier ,2004
• REVERSIBLE TRABECULAR BONE DENSITY LOSS FOLLOWING INDUCED HYPO‐OESTROGENISM WITH THE GnRH ANALOGUE BUSERELIN IN PREMENOPAUSAL WOMEN
  Clinical Endocrinology, 1988
• GnRH-agonist therapy alters calcium homoeostasis and reduces bone mineral content
  Acta Endocrinologica, 1988
• Administration of Nasal Nafarelin as Compared with Oral Danazol for Endometriosis
  New England Journal of Medicine, 1988
• Hypogonadism induced by luteinising hormone releasing hormone agonist analogues: effects on bone density in premenopausal women.
  BMJ, 1987
• LHRH ANALOGUES AND BONE LOSS
  The Lancet, 1987
• Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosis
  Fertility and Sterility, 1984
• Ulceration of the hand secondary to a radial arteriovenous fistula: a model for varicose ulceration.
  BMJ, 1983
• CLINICAL APPLICATIONS OF LHRH AND ITS ANALOGUES
  Clinical Endocrinology, 1983
• “MEDICAL OOPHORECTOMY” USING A LONG-ACTING GNRH AGONIST-A POSSIBLE NEW APPROACH TO THE TREATMENT OF ENDOMETRIOSIS.
  Journal of Clinical Endocrinology & Metabolism, 1982